DSIP
A peptide originally discovered in rabbit brains that promotes deep, restorative sleep. DSIP works differently from melatonin — it modulates your sleep architecture rather than just making you drowsy.
DSIP (Delta Sleep-Inducing Peptide) is a neuropeptide that promotes delta-wave (deep) sleep — the most restorative phase. Unlike sedatives, it works by modulating your sleep patterns rather than simply knocking you out. Research is limited but the sleep community finds it promising for improving sleep quality without next-day grogginess.
Who's interested: People with poor sleep quality (especially shallow sleepers), shift workers, those who want better deep sleep without sedation, and biohackers exploring alternatives to melatonin.
Dive deeper into the researchPotential side effects
- Mild morning drowsiness at higher doses
- Occasional headache in the first few days
- Unknown long-term safety — very limited human data
What does DSIP do?
DSIP was discovered in 1977 when researchers found that transferring blood from sleeping rabbits to awake rabbits induced delta-wave sleep patterns. It's a 9-amino-acid neuropeptide that your brain naturally produces, though the exact mechanisms are still being studied.
What makes DSIP interesting is how it promotes sleep. It doesn't sedate you. Instead, it appears to normalise your sleep architecture — increasing the proportion of deep (Stage 3) sleep where most physical restoration happens. Growth hormone secretion, tissue repair, and immune function all peak during deep sleep.
Who uses it?
- Poor sleepers — people who sleep enough hours but wake up unrefreshed (shallow sleep)
- Shift workers — those needing to reset disrupted circadian rhythms
- Recovery focus — athletes and biohackers wanting more time in deep sleep for physical recovery
- Melatonin alternatives — people who find melatonin makes them groggy or doesn't improve sleep quality
What to know before trying
DSIP has very limited human clinical data. A handful of small studies from the 1980s–90s showed promise, but modern rigorous trials are lacking. The mechanism of action is still not fully understood.
- Intranasal option exists — some users prefer nasal spray for convenience and faster onset, though absorption varies
- Often cycled — typical protocols run 2–4 weeks on, then a break
- Not a sedative — won't help you fall asleep faster if that's your issue; it's more about sleep quality
- Stacks with other sleep aids — some combine with magnesium glycinate or glycine, but interactions are unstudied
Tracking a peptide protocol?
eterni connects your labs, supplements, and retests — so you can see whether your protocol is actually working.
Get early accessFrequently Asked Questions
What is DSIP and how does it help sleep?
DSIP (Delta Sleep-Inducing Peptide) is a 9-amino-acid neuropeptide that promotes delta-wave deep sleep — the most restorative sleep phase. Unlike sedatives or melatonin, it modulates your sleep architecture to increase the proportion of deep sleep, improving recovery and restoration without next-day grogginess.
Is DSIP better than melatonin?
They work differently. Melatonin helps you fall asleep by signaling that it's nighttime. DSIP promotes deeper sleep quality once you're asleep. If your problem is falling asleep, melatonin may help more. If you sleep enough hours but wake up unrefreshed, DSIP may be more relevant. Neither has strong long-term evidence for supplementation.
How do you take DSIP?
DSIP is typically taken as a subcutaneous injection (100–300 mcg) about 30–60 minutes before bed. Intranasal sprays are also available but absorption is less predictable. Most protocols run 2–4 weeks before taking a break.
Is DSIP available in India?
DSIP is sold as a research peptide through online vendors in India. It is not approved as a drug or supplement. Quality verification is essential — always request third-party testing certificates.
How it works in your body
The exact mechanism of DSIP remains partly unclear, but research suggests it acts on multiple systems:
- GABA modulation — may enhance GABAergic signaling, promoting neuronal inhibition and relaxation
- Cortisol regulation — some evidence suggests it normalises cortisol rhythms, reducing the stress-sleep interference loop
- Opioid receptor interaction — weak interaction with opioid receptors may contribute to its calming effects
- Somatostatin connection — may influence growth hormone releasing patterns during sleep
Human evidence
- Small studies from the 1980s showed increased delta-wave sleep duration in insomnia patients
- One study found normalised sleep patterns in chronic insomnia without tolerance development over 4 weeks
- No modern, large-scale RCTs have been conducted
Side effects & safety
- Morning drowsiness — occasional at higher doses, usually resolves within an hour
- Headache — reported in some users, typically in the first few days
- Vivid dreams — increased dream recall and vividness is commonly reported
- Injection site reactions — mild redness with subcutaneous injection
- Unknown long-term safety — insufficient data for chronic use assessment
Who should avoid it: People on sedatives or opioid medications (potential interactions), pregnant or breastfeeding women, and anyone with neurological conditions.
Which labs to monitor
- Morning cortisol — DSIP may affect cortisol rhythm
- Growth hormone — deep sleep drives GH secretion
- Consider a sleep study or wearable sleep tracker to objectively measure deep sleep changes
Know what's working. Know what's not.
eterni connects your lab results, supplements, and retests — so you can see the trajectory, not just a snapshot.
Join the waitlist